BCMU
CLB icon

BlueCrest Capital Management (UK)’s Core Laboratories CLB Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,516
Closed -$754K – 525
2014
Q2 		$754K Buy
+4,516
New +$803K 0.03% 383
2014
Q1 		– Sell
-13,600
Closed -$2.6M – 519
2013
Q4 		$2.6M Buy
+13,600
New +$2.53M 0.21% 113

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

BlueCrest Capital Management (UK)'s CLB Position: Q3 2014 in Review

BlueCrest Capital Management (UK) sold out of Core Laboratories (CLB) in Q3 2014, closing a stake of 4,516 shares — an estimated $754K sold.

BlueCrest Capital Management (UK) first reported a position in CLB in Q4 2013 and held it in 2 quarters. The position peaked at $2.6M in Q4 2013. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • BlueCrest Capital Management (UK) reported no remaining Core Laboratories position as of Q3 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 4,516 Core Laboratories shares in Q3 2014, an estimated $754K.
  • BlueCrest Capital Management (UK) first reported a position in Core Laboratories in Q4 2013 and held it in 2 quarters.
  • BlueCrest Capital Management (UK)'s Core Laboratories position peaked at $2.6M in Q4 2013.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.